Cases 21 - 30 of 131
Novartis Pharmaceuticals Corporation et al v. Breckenridge Pharmaceutical, Inc.
as 1:2017cv00420
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Breckenridge Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
CESAR CASTILLO, INC. et al v. SANDOZ, INC. et al
as 2:2017cv01667
Plaintiff:
CESAR CASTILLO, INC. , 1199SEIU NATIONAL BENEFIT FUND , AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES DISTRICT COUNCIL 37 HEALTH & SECURITY PLAN and others
Defendant:
SANDOZ, INC., NOVARTIS AG, LANNETT COMPANY, INC. and others
Cause Of Action: 15 U.S.C. § 15
FWK HOLDINGS, L.L.C. et al v. LANNETT COMPANY, INC. et al
as 2:2017cv01665
Plaintiff:
FWK HOLDINGS, L.L.C. , 1199SEIU NATIONAL BENEFIT FUND, AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES DISTRICT COUNCIL 37 HEALTH & SECURITY PLAN and others
Consol_plaintiff:
CESAR CASTILLO, INC. and AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES DISTRICT COUNCIL 37 HEALTH & SECURITY PLAN
Defendant:
LANNETT COMPANY, INC. , MYLAN PHARMACEUTICALS INC. , SANDOZ, INC. and others
Cause Of Action: 15 U.S.C. § 1
CESAR CASTILLO, INC. v. FOUGERA PHARMACEUTICALS, INC. et al
as 2:2017cv01668
Plaintiff:
CESAR CASTILLO, INC.
Defendant:
FOUGERA PHARMACEUTICALS, INC., NOVARTIS AG, SANDOZ, INC. and others
Cause Of Action: 15 U.S.C. § 15
FWK HOLDINGS, L.L.C. v. FOUGERA PHARMACEUTICALS, INC. et al
as 2:2017cv01662
Plaintiff:
FWK HOLDINGS, L.L.C.
Defendant:
FOUGERA PHARMACEUTICALS, INC. , SANDOZ, INC. , NOVARTIS AG and others
Cause Of Action: 15 U.S.C. § 1
FWK HOLDINGS, L.L.C. v. FOUGERA PHARMACEUTICALS, INC. et al
as 2:2017cv01663
Plaintiff:
FWK HOLDINGS, L.L.C.
Defendant:
FOUGERA PHARMACEUTICALS, INC. , SANDOZ, INC. , NOVARTIS AG and others
Cause Of Action: 15 U.S.C. § 2
Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00393
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.
as 1:2017cv00389
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Mylan Pharmaceuticals Inc.
Counter_claimant:
Mylan Pharmaceuticals Inc.
Counter_defendant:
Novartis AG and Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
NOVARTIS AG et al v. AUROBINDO PHARMA LTD. et al
as 2:2017cv00389
Plaintiff:
NOVARTIS AG , NOVARTIS PHARMACEUTICALS CORPORATION , MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 15 U.S.C. § 1126
Novartis AG et al v. Aurobindo Pharma Ltd. et al
as 1:2017cv00048
Plaintiff:
Novartis AG , Novartis Pharmaceuticals Corporation , Mitsubishi Tanabe Pharma Corporation and others
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 145
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
